“Cutaneous Safety Profile of Nemolizumab in Moderate‑to‑Severe Atopic Dermatitis and Prurigo Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2) Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2)”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s748. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/4121.